Senti Biosciences Holdings (SNTI) Income from Discontinued Operations (2022 - 2023)
Senti Biosciences Holdings (SNTI) posted Income from Discontinued Operations of -$28000.0 for Q4 2023, down 100.13% on a QoQ basis from $21.7 million in Q3 2023, and up 99.67% year-over-year from -$14023.0 in Q4 2022.
Analysis
Senti Biosciences Holdings (SNTI) Income from Discontinued Operations (2022 - 2023) Analysis & Trends
Senti Biosciences Holdings has reported Income from Discontinued Operations for 2 years, with the latest figure at -$28000.0 in Q4 2023.
- On a quarterly basis, Income from Discontinued Operations rose 99.67% year-over-year to -$28000.0 in Q4 2023; TTM through Sep 2024 was -$28000.0, a 100.73% decrease from a year earlier, with the FY2023 full-year figure at $12.3 million, up 244.51% from the prior year.
- Income from Discontinued Operations was -$28000.0 for Q4 2023 at Senti Biosciences Holdings, down from $21.7 million in the prior quarter.
- The five-year high for Income from Discontinued Operations was $21.7 million in Q3 2023, with the low at -$8.5 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn | - |
| 10 | Senti Biosciences Holdings | 9.61 Mn | 9.61 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -28,000.00 |
| Sep 30, 2023 | 21.69 Mn |
| Jun 30, 2023 | -4.45 Mn |
| Mar 31, 2023 | -4.87 Mn |
| Dec 31, 2022 | -8.55 Mn |
| Sep 30, 2022 | -2.34 Mn |